THE US Food and Drug Administration's Commissioner Scott Gottlieb has announced a program to support faster development of generic copies of "complex drugs" which are more difficult to "genericise".
The FDA is starting with transdermally delivered drugs.
Visit fda.gov for more.
The above article was sent to subscribers in Pharmacy Daily's issue from 12 Oct 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Oct 18
